Literature DB >> 22020208

ESR1 gene amplification: another mechanism regulating the cellular levels of ERα.

Ke-Da Yu, Zhi-Ming Shao.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22020208     DOI: 10.1038/nrc3093-c1

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  14 in total

1.  Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes.

Authors:  Cathy B Moelans; Roel A de Weger; Hanneke N Monsuur; Raymon Vijzelaar; Paul J van Diest
Journal:  Mod Pathol       Date:  2010-05-14       Impact factor: 7.842

2.  ESR1 gene amplification in breast cancer: a common phenomenon?

Authors:  Anne Vincent-Salomon; Virginie Raynal; Carlo Lucchesi; Nadège Gruel; Olivier Delattre
Journal:  Nat Genet       Date:  2008-07       Impact factor: 38.330

3.  ESR1 gene amplification in breast cancer: a common phenomenon?

Authors:  Jorge S Reis-Filho; Suzanne Drury; Maryou B Lambros; Caterina Marchio; Nichola Johnson; Rachael Natrajan; Janine Salter; Pauline Levey; Olivia Fletcher; Julian Peto; Alan Ashworth; Mitch Dowsett
Journal:  Nat Genet       Date:  2008-07       Impact factor: 38.330

4.  ESR1 gene amplification in breast cancer: a common phenomenon?

Authors:  Hugo M Horlings; Anna Bergamaschi; Silje H Nordgard; Young H Kim; Wonshik Han; Dong-Young Noh; Keyan Salari; Simon A Joosse; Fabien Reyal; Ole Christian Lingjaerde; Vessela N Kristensen; Anne-Lise Børresen-Dale; Jonathan Pollack; Marc J van de Vijver
Journal:  Nat Genet       Date:  2008-07       Impact factor: 38.330

5.  Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers.

Authors:  S-F Chin; Y Wang; N P Thorne; A E Teschendorff; S E Pinder; M Vias; A Naderi; I Roberts; N L Barbosa-Morais; M J Garcia; N G Iyer; T Kranjac; J F R Robertson; S Aparicio; S Tavaré; I Ellis; J D Brenton; C Caldas
Journal:  Oncogene       Date:  2006-09-25       Impact factor: 9.867

Review 6.  The different roles of ER subtypes in cancer biology and therapy.

Authors:  Christoforos Thomas; Jan-Åke Gustafsson
Journal:  Nat Rev Cancer       Date:  2011-07-22       Impact factor: 60.716

7.  ESR1 gene amplification in breast cancer: a common phenomenon?

Authors:  Lindsay A Brown; Jeremy Hoog; Suet-Feung Chin; Yu Tao; Abd Alnaser Zayed; Koei Chin; Andrew E Teschendorff; John F Quackenbush; John C Marioni; Samuel Leung; Charles M Perou; Torsten O Neilsen; Matthew Ellis; Joe W Gray; Philip S Bernard; David G Huntsman; Carlos Caldas
Journal:  Nat Genet       Date:  2008-07       Impact factor: 38.330

8.  Oestrogen receptor gene (ESR1) amplification is frequent in endometrial carcinoma and its precursor lesions.

Authors:  A Lebeau; Tj Grob; F Holst; N Seyedi-Fazlollahi; H Moch; Luigi Terracciano; A Turzynski; M Choschzick; G Sauter; R Simon
Journal:  J Pathol       Date:  2008-10       Impact factor: 7.996

9.  Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.

Authors:  Frederik Holst; Phillip R Stahl; Christian Ruiz; Olaf Hellwinkel; Zeenath Jehan; Marc Wendland; Annette Lebeau; Luigi Terracciano; Khawla Al-Kuraya; Fritz Jänicke; Guido Sauter; Ronald Simon
Journal:  Nat Genet       Date:  2007-04-08       Impact factor: 38.330

10.  Gene amplification in ductal carcinoma in situ of the breast.

Authors:  L Burkhardt; T J Grob; I Hermann; E Burandt; M Choschzick; F Jänicke; V Müller; C Bokemeyer; R Simon; G Sauter; W Wilczak; A Lebeau
Journal:  Breast Cancer Res Treat       Date:  2009-12-22       Impact factor: 4.872

View more
  2 in total

1.  On the evidence for ESR1 amplification in breast cancer.

Authors:  Frederik Holst; Cathy B Moelans; Martin Filipits; Christian F Singer; Ronald Simon; Paul J van Diest
Journal:  Nat Rev Cancer       Date:  2012-01-24       Impact factor: 60.716

Review 2.  Computer-Aided Ligand Discovery for Estrogen Receptor Alpha.

Authors:  Divya Bafna; Fuqiang Ban; Paul S Rennie; Kriti Singh; Artem Cherkasov
Journal:  Int J Mol Sci       Date:  2020-06-12       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.